Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Moxidectin Versus Ivermectin as Mass Drug Administration for the Control of Onchocerciasis and Other Neglected Tropical Diseases: A Cluster-randomised Trial

NCT07145736 is registered in ClinicalTrials.gov with Kirby Institute as lead sponsor.

NCT NCT07145736
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07145736 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Moxidectin Versus Ivermectin as Mass Drug Administration for the Control of Onchocerciasis and Other Neglected Tropical Diseases: A Cluster-randomised Trial
Lead sponsor
Kirby Institute
Phase
Phase 4
Overall status
Recruiting
Start date
August 4, 2025
Completion date
June 30, 2029
Enrollment
52,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ascaris lumbricoides infection, hookworm infections, onchocerciasis, scabies, trichuris trichiura; infection